(1989; 1 page)
After the Cuban revolution, Cuba’s pharmaceutical companies were nationalized, and have since established new plants and equipment that improved productivity and quality. In 1986, Cuba decided to centralize all drug-related commerce under the supervision of the Ministry of Public Health (MINSAP). The Ministry is responsible for overseeing drug production, circulation, distribution, importation, exportation, standardization and research. At the time of the article, Cuba could produce 85% of drugs consumed in the country from raw imported materials. Rational use is the cornerstone of Cuba’s national drug policy; other objectives are listed in the article. Areas of focus are quality control, research, supply systems, and practical training of medical and health personnel. Cuba’s policy’s success is indicated by the country’s infant mortality of 13.3 per 1,000 live births, and life expectancy of over 70 years. Both of these measures are comparable to those of developed countries, thus showing the value of an integrated health policy.
Abstract written by M. Tobin, 2013.